# A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

> **NCT03770988** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 49 (estimated)

## Conditions studied

- Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma

## Interventions

- **DRUG:** Treatment with Poziotinib

## Key facts

- **NCT ID:** NCT03770988
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-08-31
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03770988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03770988, "A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03770988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*